Literature DB >> 24590399

Aspidosperma species as sources of antimalarials. Part III. A review of traditional use and antimalarial activity.

Renata Cristina de Paula1, Maria Fâni Dolabela2, Alaíde Braga de Oliveira1.   

Abstract

Several plant species belonging to the genus Aspidosperma are traditionally used in Brazil and other Meso- and South American countries for the treatment of malaria and fevers. These traditional uses were motivation for this review. A literature survey completed for this review has identified scientific bibliographical references to the use of 24 Aspidosperma species to treat malaria/fevers and to 19 species that have had their extracts and/or alkaloids evaluated, with good results, for in vitro and/or in vivo antimalarial activity. Indole alkaloids are typical constituents of Aspidosperma species. However, only 20 out of more than 200 known indole alkaloids isolated from this genus have been assayed for antimalarial activity. These data support the potential of Aspidosperma species as sources of antimalarials and the importance of research aimed at validating their use in the treatment of human malaria. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24590399     DOI: 10.1055/s-0034-1368168

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  2 in total

1.  Quorum sensing inhibitory effect of bergamot oil and aspidosperma extract against Chromobacterium violaceum and Pseudomonas aeruginosa.

Authors:  Sarah Omar Ahmed; Hamdallah Hafez Zedan; Yasser Musa Ibrahim
Journal:  Arch Microbiol       Date:  2021-06-27       Impact factor: 2.552

2.  Aspidosperma species as sources of anti-malarials: uleine is the major anti-malarial indole alkaloid from Aspidosperma parvifolium (Apocynaceae).

Authors:  Maria Fâni Dolabela; Marinete Marins Póvoa; Geraldo Célio Brandão; Fabíola Dutra Rocha; Luciana Ferreira Soares; Renata Cristina de Paula; Alaíde Braga de Oliveira
Journal:  Malar J       Date:  2015-12-10       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.